Trainor Iii Eugene A - Net Worth and Insider Trading

Trainor Iii Eugene A Net Worth

The estimated net worth of Trainor Iii Eugene A is at least $117 Million dollars as of 2024-04-26. Trainor Iii Eugene A is the 10% Owner of Echo Global Logistics Inc and owns about 2,420,219 shares of Echo Global Logistics Inc (ECHO) stock worth over $117 Million. Trainor Iii Eugene A is the 10% Owner of Catalyst Biosciences Inc and owns about 3,333 shares of Catalyst Biosciences Inc (CBIO) stock worth over $25,562. Trainor Iii Eugene A is also the 10% Owner of ARYx Therapeutics Inc and owns about 4,469,274 shares of ARYx Therapeutics Inc (ARYX) stock worth over $2,235. Besides these, Trainor Iii Eugene A also holds Novation Companies Inc (NOVCQ) . Details can be seen in Trainor Iii Eugene A's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Trainor Iii Eugene A has not made any transactions after 2009-10-01 and currently still holds the listed stock(s).

Transaction Summary of Trainor Iii Eugene A

Trainor Iii Eugene A Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Trainor Iii Eugene A owns 13 companies in total, including Sunesis Pharmaceuticals Inc (SNSS) , Echo Global Logistics Inc (ECHO) , and W World Corp (WWHC) among others .

Click here to see the complete history of Trainor Iii Eugene A’s form 4 insider trades.

Insider Ownership Summary of Trainor Iii Eugene A

Ticker	Comapny	Transaction Date	Type of Owner
SNSS	Sunesis Pharmaceuticals Inc	2009-10-30	10 percent owner
ECHO	Echo Global Logistics Inc	2009-10-01	10 percent owner
WWHC	W World Corp	2009-05-08	10 percent owner
IQNT	Inteliquent Inc	2009-02-20	10 percent owner
PRTK	Paratek Pharmaceuticals Inc	2006-05-09	10 percent owner
ARYX	ARYx Therapeutics Inc	2008-11-14	10 percent owner
GLUU	Glu Mobile Inc	2008-03-03	10 percent owner
CBIO	Catalyst Biosciences Inc	2006-04-12	10 percent owner
INWK	InnerWorkings Inc	2007-11-09	10 percent owner
FOLD	Amicus Therapeutics Inc	2007-05-30	10 percent owner
VG	Vonage Holdings Corp	2006-05-23	10 percent owner
ARDMQ	Aradigm Corp	2004-01-07	10 percent owner
VIRX	Viracta Therapeutics Inc	2009-04-03	10 percent owner

Trainor Iii Eugene A Latest Holdings Summary

Trainor Iii Eugene A currently owns a total of 4 stocks. Among these stocks, Trainor Iii Eugene A owns 2,420,219 shares of Echo Global Logistics Inc (ECHO) as of October 1, 2009, with a value of $117 Million and a weighting of 99.98%. Trainor Iii Eugene A owns 3,333 shares of Catalyst Biosciences Inc (CBIO) as of April 12, 2006, with a value of $25,562 and a weighting of 0.02%. Trainor Iii Eugene A also owns 4,469,274 shares of ARYx Therapeutics Inc (ARYX) as of November 14, 2008, with a value of $2,235 and a weighting of 0%. The other 1 stocks Novation Companies Inc (NOVCQ) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Trainor Iii Eugene A

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ECHO	Echo Global Logistics Inc	2009-10-01	2,420,219	48.24	116,751,365
CBIO	Catalyst Biosciences Inc	2006-04-12	3,333	7.67	25,562
ARYX	ARYx Therapeutics Inc	2008-11-14	4,469,274	0.00	2,235
NOVCQ	Novation Companies Inc	2006-05-15	1,225,179	0.00	123

Holding Weightings of Trainor Iii Eugene A

Trainor Iii Eugene A Form 4 Trading Tracker

According to the SEC Form 4 filings, Trainor Iii Eugene A has made a total of 0 transactions in Echo Global Logistics Inc (ECHO) over the past 5 years. The most-recent trade in Echo Global Logistics Inc is the sale of 0 shares on October 1, 2009, which brought Trainor Iii Eugene A around $0.

According to the SEC Form 4 filings, Trainor Iii Eugene A has made a total of 0 transactions in Catalyst Biosciences Inc (CBIO) over the past 5 years. The most-recent trade in Catalyst Biosciences Inc is the acquisition of 3,333 shares on April 12, 2006, which cost Trainor Iii Eugene A around $3 Million.

According to the SEC Form 4 filings, Trainor Iii Eugene A has made a total of 0 transactions in ARYx Therapeutics Inc (ARYX) over the past 5 years. The most-recent trade in ARYx Therapeutics Inc is the sale of 0 shares on November 14, 2008, which brought Trainor Iii Eugene A around $0.

More details on Trainor Iii Eugene A's insider transactions can be found in the Insider Trading History of Trainor Iii Eugene A table.

Insider Trading History of Trainor Iii Eugene A

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Trainor Iii Eugene A Trading Performance

GuruFocus tracks the stock performance after each of Trainor Iii Eugene A's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Trainor Iii Eugene A is -13.16%. GuruFocus also compares Trainor Iii Eugene A's trading performance to market benchmark return within the same time period. The performance of stocks bought by Trainor Iii Eugene A within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Trainor Iii Eugene A's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Trainor Iii Eugene A

Average Return

-39.02%

Average return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-12.02	-13.16	-19.12	-39.02	-48.04	-52.74
Relative Return to S&P 500(%)	-10.66	-11.67	-25.96	-53.21	-51.33	-40.38

Trainor Iii Eugene A Ownership Network

Ownership Network List of Trainor Iii Eugene A

No Data

Ownership Network Relation of Trainor Iii Eugene A

Trainor Iii Eugene A Owned Company Details

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Trainor Iii Eugene A is the 10 percent owner of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Echo Global Logistics Inc do?

Who are the key executives at Echo Global Logistics Inc?

Trainor Iii Eugene A is the 10 percent owner of Echo Global Logistics Inc. Other key executives at Echo Global Logistics Inc include director & Chief Executive Officer Douglas R Waggoner , Chief Financial Officer David B Menzel , and Controller Douglas Hong .

Echo Global Logistics Inc (ECHO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Echo Global Logistics Inc (ECHO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Echo Global Logistics Inc (ECHO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Echo Global Logistics Inc (ECHO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Echo Global Logistics Inc Insider Transactions

No Available Data

What does W World Corp do?

Who are the key executives at W World Corp?

Trainor Iii Eugene A is the 10 percent owner of W World Corp. Other key executives at W World Corp include director & 10 percent owner Anthony B Evnin , director & 10 percent owner Newhall Charles W Iii , and President and CFO Neill Sydney Colin .

W World Corp (WWHC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of W World Corp (WWHC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of W World Corp (WWHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

W World Corp (WWHC)'s detailed insider trading history can be found in Insider Trading Tracker table.

W World Corp Insider Transactions

No Available Data

What does Inteliquent Inc do?

Who are the key executives at Inteliquent Inc?

Trainor Iii Eugene A is the 10 percent owner of Inteliquent Inc. Other key executives at Inteliquent Inc include director & President and CEO Matthew Jr Carter , Chief Financial Officer / EVP Kurt Abkemeier , and 10 percent owner C Richard Kramlich .

Inteliquent Inc (IQNT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Inteliquent Inc (IQNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inteliquent Inc (IQNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Inteliquent Inc (IQNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inteliquent Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Trainor Iii Eugene A is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Trainor Iii Eugene A made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 181,011 shares made by Evan Loh , a net sale of 104,375 shares made by Michael Bigham , and a net sale of 83,909 shares made by William M. Haskel .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 469,621 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 788,500 shares were bought by its insiders, resulting in a net purchase of 318,879 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does ARYx Therapeutics Inc do?

Who are the key executives at ARYx Therapeutics Inc?

Trainor Iii Eugene A is the 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Growth Equity Opportunities Fund, Llc , and 10 percent owner Mark W Perry .

ARYx Therapeutics Inc (ARYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYx Therapeutics Inc Insider Transactions

No Available Data

What does Glu Mobile Inc do?

Who are the key executives at Glu Mobile Inc?

Trainor Iii Eugene A is the 10 percent owner of Glu Mobile Inc. Other key executives at Glu Mobile Inc include EVP & COO and CFO Eric R Ludwig , Senior Vice President & Revenue Becky Ann Hughes , and SVP & Business & Corp. Dev. Chris Akhavan .

Glu Mobile Inc (GLUU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Glu Mobile Inc (GLUU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Glu Mobile Inc (GLUU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Glu Mobile Inc (GLUU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Glu Mobile Inc Insider Transactions

No Available Data

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Trainor Iii Eugene A is the 10 percent owner of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Catalyst Biosciences Inc Insider Transactions

No Available Data

What does InnerWorkings Inc do?

Who are the key executives at InnerWorkings Inc?

Trainor Iii Eugene A is the 10 percent owner of InnerWorkings Inc. Other key executives at InnerWorkings Inc include director & President and CEO Richard S Stoddart , Chief Accounting Officer John Bosshart , and Executive VP and CFO Donald W Pearson .

InnerWorkings Inc (INWK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of InnerWorkings Inc (INWK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InnerWorkings Inc (INWK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

InnerWorkings Inc (INWK)'s detailed insider trading history can be found in Insider Trading Tracker table.

InnerWorkings Inc Insider Transactions

No Available Data

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Trainor Iii Eugene A is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Trainor Iii Eugene A made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 645,546 shares made by John F Crowley , a net sale of 258,416 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .

In summary, during the past 3 months, insiders sold 185,169 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 185,169 shares. During the past 18 months, 1,242,298 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,242,298 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

What does Vonage Holdings Corp do?

Who are the key executives at Vonage Holdings Corp?

Trainor Iii Eugene A is the 10 percent owner of Vonage Holdings Corp. Other key executives at Vonage Holdings Corp include SVP Corporate Development Vinod Lala , Interim Chief Legal Officer Randy K. Rutherford , and director & Chief Executive Officer Rory P Read .

Vonage Holdings Corp (VG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vonage Holdings Corp (VG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vonage Holdings Corp (VG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vonage Holdings Corp (VG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vonage Holdings Corp Insider Transactions

No Available Data

What does Aradigm Corp do?

Who are the key executives at Aradigm Corp?

Trainor Iii Eugene A is the 10 percent owner of Aradigm Corp. Other key executives at Aradigm Corp include 10 percent owner Bleichroeder Lp , 10 percent owner First Eagle Investment Management, Llc , and 10 percent owner 21 April Fund Lp .

Aradigm Corp (ARDMQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aradigm Corp (ARDMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aradigm Corp (ARDMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aradigm Corp (ARDMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aradigm Corp Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

Trainor Iii Eugene A is the 10 percent owner of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

Over the past 18 months, Trainor Iii Eugene A made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 21,403 shares made by Daniel R. Chevallard , a net sale of 4,272 shares made by Lisa Rojkjaer , and a net purchase of 100,000 shares made by Mark Rothera .

In summary, during the past 3 months, insiders sold 3,405 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 3,405 shares. During the past 18 months, 25,675 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 74,325 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

Trainor Iii Eugene A Mailing Address

Above is the net worth, insider trading, and ownership report for Trainor Iii Eugene A. You might contact Trainor Iii Eugene A via mailing address: New Enterprise Associates, 1119 St Paul Street, Baltimore Md 21202.

Discussions on Trainor Iii Eugene A

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.